Neuraptive Therapeutics has secured an exclusive licence from Washington University in St. Louis for a bioresorbable wireless electronic stimulation device designed for peripheral nerve repair.

HistoSonics will now initiate a phased commercial rollout of its Edison system across European centres of excellence that specialise in liver tumour treatment.

The funds will support the construction of a new manufacturing facility and make significant upgrades to Otsuka ICU Medical's existing manufacturing site in Austin, Texas.

Swiss spine surgery company Neo Medical has commercially launched the Neo Instant MIS Access platform in the US.

Hyperfine has commercially launched its next-generation Swoop portable MRI system (Model 2) in select European markets.

Under the deal, Ottobock will inherit Fesia Technology’s portfolio of functional electrical stimulation (FES) products used in neurorehabilitation.

Philips has expanded its ultrasound portfolio with the launch of the Alturion system, which features AI-powered workflows and is intended for high-volume clinical environments.

Funds will support Materna’s completion of a pivotal trial evaluating its system for reducing pelvic floor muscle injury during childbirth, as well as other commercial activities.

The company has since learned the cyberattack was caused by a third-party contractor’s user session within its cloud-based system being compromised.

The companies will combine their expertise to develop a ‘tuneable’ presbyopia-correcting intraocular lens (PCIOL) for cataract patients.

Resmed’s decision to sell MatrixCare to PE firm Frazier Healthcare Partners comes less than a decade after its $750m acquisition of the software business.

VB Spine has signed a definitive agreement with Augmedics to acquire the exclusive rights to the CT-Fluoro technology for spine applications.